International mRCC Database Consortium
Working Together Against Kidney Cancer
IMDC Risk Calculator
Karnofsky Performance status
Is the Karnofsky Performance status < 80%?
Karnofsky Performance Status <80% is roughly equivalent to ECOG Performance status ≥ 2Time from diagnosis to treatment
Has it been < 1 year from time of diagnosis to systemic therapy?
Time from any initial diagnosis (including localized RCC) to when first systemic therapy is started for metastatic diseaseHemoglobin < Lower limit of normal
Usually ~120 g/L (12.0 mg/dL) for females and ~135 g/L (13.5 mg/dL) for males*
Neutrophils > Upper limit of normal
Usually ~7-8 x 109/L or 7000-8000/mm3*
Platelets > Upper limit of normal
Usually ~400-450 cells/µL*
Corrected Calcium > Upper limit of normal
Usually ~2.6 mmol/L or ~ 10.6 mg/dL*
Favourable risk
0 factors
Median Survival:
43 months
*Because normal ranges vary between laboratories, use limits of normal set by the laboratory performing the tests.
Instructions
@IMDCOnline Twitter Feed
-
RT @ZiadBakouny: Post-call in the CCU, so late in sharing this but thrilled to see our work on upfront cytoreductive nephrectomy in… https://t.co/RpkzQfSGD3
-
RT @DrChoueiri: JUST IN: Cytoreductive Nephrectomy for Metastatic RCC Treated with Immune Checkpoint Inhibitors or Targeted Therapy… https://t.co/hPJR2zVUpv
-
RT @anobelodisho: Using nomograms in the real world is tricky and hides clinical variation. We built an interactive viz for… https://t.co/Dn2SQ6Pbss